15Associates and joint ventures
|
millions of CHF |
|
2025 |
|
2024 |
|
Balance as of January 1 |
|
53.0 |
|
54.7 |
|
Impairment 1) |
|
–10.1 |
|
– |
|
Acquired through business combination |
|
0.1 |
|
– |
|
Disposal |
|
–2.5 |
|
– |
|
Share of profit / (loss) of associates and joint ventures |
|
–1.3 |
|
–3.8 |
|
Dividend payments received |
|
– |
|
–0.1 |
|
Currency translation differences |
|
–2.0 |
|
2.1 |
|
Total investments in associates and joint ventures as of December 31 |
|
37.1 |
|
53.0 |
|
- thereof investments in associates: |
|
36.9 |
|
52.8 |
|
- thereof investments in joint ventures: |
|
0.2 |
|
0.2 |
1) Impairment has been reported in the consolidated income statement within line share of profit / (loss) of associates and joint ventures.
In March 2025, the Group sold its shares in Tamturbo Oyi for CHF 6.8 million which resulted in a net gain of CHF 3.7 million in other operating income. In 2025, Sulzer recorded an impairment loss of CHF 8.0 million related to its shareholding in Fuenix Ecogy Holding B.V.